Literature DB >> 12181039

Immunotherapy for post-transplant lymphoproliferative disease.

Karin C M Straathof1, Barbara Savoldo, Helen E Heslop, Cliona M Rooney.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12181039     DOI： 10.1046/j.1365-2141.2002.03594.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  6 in total

1.  Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs).

Authors:  Barbara Savoldo; John A Goss; Markus M Hammer; Lan Zhang; Teresita Lopez; Adrian P Gee; Yu-Feng Lin; Ruben E Quiros-Tejeira; Petra Reinke; Stephan Schubert; Stephen Gottschalk; Milton J Finegold; Malcolm K Brenner; Cliona M Rooney; Helen E Heslop
Journal:  Blood       Date:  2006-07-11       Impact factor: 22.113

Review 2.  Posttransplant lymphoproliferative disease following liver transplantation.

Authors:  Kala Y Kamdar; Cliona M Rooney; Helen E Heslop
Journal:  Curr Opin Organ Transplant       Date:  2011-06       Impact factor: 2.640

3.  Clinical characteristics and outcomes of posttransplant lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation in Korea.

Authors:  Sun Hee Park; Su Mi Choi; Dong Gun Lee; Jung Hyun Choi; Jin Hong Yoo; Hee Je Kim; Dong Wook Kim; Jong Wook Lee; Woo Sung Min; Wan Shik Shin; Chun Choo Kim
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

Review 4.  Immunotherapy of human cancers using gene modified T lymphocytes.

Authors:  Juan F Vera; Malcolm K Brenner; Gianpietro Dotti
Journal:  Curr Gene Ther       Date:  2009-10       Impact factor: 4.391

5.  Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506).

Authors:  Biagio De Angelis; Gianpietro Dotti; Concetta Quintarelli; Leslie E Huye; Lan Zhang; Ming Zhang; Fabrizio Pane; Helen E Heslop; Malcolm K Brenner; Cliona M Rooney; Barbara Savoldo
Journal:  Blood       Date:  2009-09-16       Impact factor: 22.113

6.  Cytolytic CD4(+)-T-cell clones reactive to EBNA1 inhibit Epstein-Barr virus-induced B-cell proliferation.

Authors:  Sarah Nikiforow; Kim Bottomly; George Miller; Christian Münz
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.